52
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization

, , , , &
Pages 991-998 | Published online: 29 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Na Wang, Hongzhi Xu, Qing Li, Xiaosheng Fang, Jie Liu, Xiaohui Sui, Lingyan Zhang, Yujie Jiang & Xin Wang. (2020) Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data. Cancer Management and Research 12, pages 5881-5891.
Read now

Articles from other publishers (4)

Kayvan Mohkam, Raëf Abdallah, Gisèle N’kontchou, Nathalie Ganne, Louise Barbier, Ephrem Salamé, Petru Bucur, Michel Rayar, Fabien Robin, Karim Boudjema, Daniel Pietrasz, Daniel Cherqui, René Adam, Chetana Lim, Eric Savier, Olivier Scatton, Charlotte Maulat, Bertrand Suc, Fabrice Muscari, Alexis Laurent, Christophe Duvoux, Bruno Heyd, Célia Turco, Alexandre Doussot, Philippe Merle, Teresa Antonini, Mickaël Lesurtel, Cyril Cossé, François Durand, Olivier Soubrane, François Cauchy & Jean-Yves Mabrut. (2021) Influence of the ABO Blood Group System on Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation 106:7, pages 1411-1420.
Crossref
Faiza Essawy, Hoda Sadek, Sara Abdelaty, Manal Zahran, Bothaina Madkour, Karim Mashhour, Alaa Ismail & Dalia Amin. (2020) ABO blood group genotypes and risk of hepatocellular carcinoma in a cohort of Egyptian patients. Gene Reports 21, pages 100760.
Crossref
Shuang-Shuang Li, Cong-Ya Zhou, Rong Liao, Lai Xiong, Ning-Na Weng, Ya-Qin Zhao, Clifford Mason, Hong-Feng Gou, Cheng Yi & Qing Zhu. (2020) ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma. Medicine 99:14, pages e19413.
Crossref
Alihan Oral & Tolga Sahin. (2019) Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma. Scientific Reports 9:1.
Crossref